Denali Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Denali Therapeutics Inc. (DNLI) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.170.131.340.291.470.420.46
Short-Term Investments0.660.911.120.570.960.000.00
Cash & Short-Term Investments0.831.031.340.871.470.420.46
Accounts Receivable0.000.000.010.000.010.000.00
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.030.030.020.030.010.000.00
Total Current Assets0.861.061.370.901.500.430.48
Non-Current Assets
Property, Plant & Equipment (Net)0.130.070.070.070.070.080.03
Long-Term Investments0.360.000.000.430.030.000.00
Other Non-Current Assets0.020.020.010.010.000.000.01
Total Non-Current Assets0.510.090.090.510.110.120.18
Total Assets1.371.151.461.401.600.550.66
Current Liabilities
Accounts Payable0.010.010.070.000.000.010.00
Short-Term Debt0.010.000.000.000.000.000.00
Accrued Liabilities0.060.060.040.030.040.000.00
Deferred Revenue0.000.000.290.320.020.000.00
Other Current Liabilities0.080.020.000.350.050.000.02
Total Current Liabilities0.100.080.360.380.070.050.03
Non-Current Liabilities
Long-Term Debt0.040.040.050.060.060.070.00
Other Non-Current Liabilities0.010.000.000.000.000.000.00
Total Non-Current Liabilities0.040.040.050.060.390.110.08
Total Liabilities0.140.120.420.440.450.160.12
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-1.54-1.12-0.98-0.64-0.35-0.43-0.23
Accumulated Other Comprehensive Income0.000.00-0.010.000.000.000.00
Additional Paid-in Capital2.762.142.021.611.500.820.77
Shares Outstanding0.140.140.140.120.000.000.00
Total Stockholders' Equity1.231.031.040.961.150.390.55
Total Liabilities & Equity1.371.151.461.401.600.550.66